Основная статистика
| CIK | 916444 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Paradigm Medical Industries, Inc.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| August 10, 2009 |
PARADIGM MEDICAL INDUSTRIES, INC. 2355 South 1070 West Salt Lake City, Utah 84119 USA Telephone: (801) 977-8970 Facsimile: (801) 977-8973 August 10, 2009 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E., Mail Stop 6010 Washington, D.C. 20549 Attn: Kevin L. Vaughn Accounting Branch Chief Re: Paradigm Medical Industries, Inc. Form 10-K for the Fiscal Ye |
|
| August 10, 2009 |
FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): August 10, 2009 PARADIGM MEDICAL INDUSTRIES, INC. |
|
| August 10, 2009 |
15-12G 1 pmedform1520090810.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM 15-12G AUGUST 10, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission Fil |
|
| August 5, 2009 |
EXHIBIT 10.35 Letter of Understanding The following is the letter of understanding between CSO srl, located at Via degli Stagnacci, 12/e Badia A Settimo, 50010 Italy (CSO) and Paradigm Medical Industries, Inc., located at 2355 South 1070 West Salt Lake City, UTAH 84119, United States of America, (Paradigm) It is agreed between CSO and Paradigm that: 1) CSO will manufacture and supply products for |
|
| August 5, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q/A 10-Q/A 1 pmed10qa20090331.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM 10-Q/A MARCH 31, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q/A x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Per |
|
| June 24, 2009 |
FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): June 23, 2009 PARADIGM MEDICAL INDUSTRIES, INC. |
|
| June 16, 2009 |
FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 29, 2009 PARADIGM MEDICAL INDUSTRIES, INC. |
|
| May 15, 2009 |
EX-10.35 2 pmed10q20090331ex10-35.htm LETTER OF UNDERSTANDING EXHIBIT 10.35 Letter of Understanding The following is the letter of understanding between CSO srl, located at Via degli Stagnacci, 12/e Badia A Settimo, 50010 Italy (CSO) and Paradigm Medical Industries, Inc., located at 2355 South 1070 West Salt Lake City, UTAH 84119, United States of America, (Paradigm) It is agreed between CSO and P |
|
| May 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q 10-Q 1 pmed10q20090331.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM 10-Q MARCH 31, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period Fro |
|
| April 15, 2009 |
10-K 1 pmed10k123108.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM 10-K DECEMBER 31, 2008 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008, or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transit |
|
| April 15, 2009 |
April 15, 2009 CONFIDENTIAL LETTER OF INTENT Paradigm Medical Industries, Inc. 2355 South 1070 West Salt Lake City, UT 84119 Dear Sir or Madam: On the terms and subject to the conditions set forth below, Fairhills Capital Offshore, LLC (the ?Investor?) will commit to financing $1,800,000 in promissory notes to Paradigm Medical Industries, Inc. (the ?Issuer?) on the principal terms set forth below. |
|
| April 1, 2009 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-28498 (Check one) |X| Form 10-K || Form 11-K || Form 20-F || Form 10-Q || Form N-SAR For period ended: December 31, 2008 || Transition Report on Form 10-K || Transition Report on Form 20-F || Transition Report on Form 11-K || Transition Report on Form 10-Q || Transition Report on Form N-SAR For the transition period ended Read Attached Instruction Sheet Before Preparing Form. |
|
| December 29, 2008 |
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. |
|
| December 8, 2008 |
8-K 1 pmi8k120508.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM 8-K DECEMBER 5, 2008 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): December 5, 2008 PARADIGM MEDICAL INDUSTRIES, INC. (Exact name of registrant as specified in this Charter) Delaware |
|
| November 21, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): November 18, 2008 PARADIGM MEDICAL INDUSTRIES, INC. (Exact name of registrant as specified in this Charter) Delaware 0-28498 87-0459536 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 19, 2008 |
10-Q 1 paradigm10q093008.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM 10-Q SEPTEMBER 30, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q : QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2008 9 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition |
|
| November 17, 2008 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING NT 10-Q 1 paradigmnt10q093008.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM NT 10-Q SEPTEMBER 30, 2008 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-28498 (Check one) || Form 10-K and Form 10-KSB || Form 11-K || Form 20-F |X| Form 10-Q and Form 10-QSB || Form N-SAR For period ended: September 30, 2008 || Transition Report on F |
|
| November 12, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant : Filed by a Party other than the Registrant 9 Check the appropriate box: 9 Preliminary Proxy Statement 9 Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(3)(2)) : Definitive Proxy Statement 9 Definitive Additional Materials 9 Soliciting Material Pursuant to §240. |
|
| October 23, 2008 |
PARADIGM MEDICAL INDUSTRIES, INC. 2355 South 1070 West Salt Lake City, Utah 84119 USA Telephone: (801) 977-8970 Facsimile: (801) 977-8973 October 23, 2008 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E., Mail Stop 6010 Washington, D.C. 20549 Attn: Kevin L. Vaughn Accounting Branch Chief Re: Paradigm Medical Industries, Inc. Amended Form 10-KSB for th |
|
| October 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q/A x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 0-28498 PARADIGM MEDICAL INDUSTRIES, INC. (Exact name of |
|
| October 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q/A : QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2008 9 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 0-28498 PARADIGM MEDICAL INDUSTRIES, INC. (Exact name o |
|
| September 29, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-KSB/A-3 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2007, or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 0-28498 Paradigm Medical Industries, In |
|
| September 29, 2008 |
PARADIGM MEDICAL INDUSTRIES, INC. 2355 South 1070 West Salt Lake City, Utah 84119 USA Telephone: (801) 977-8970 Facsimile: (801) 977-8973 September 26, 2008 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E., Mail Stop 6010 Washington, D.C. 20549 Attn: Kevin L. Vaughn Accounting Branch Chief Re: Paradigm Medical Industries, Inc. Form 10-KSB for the Fisc |
|
| September 25, 2008 |
8-K 1 pmi8k092208.htm PARADIGM MEDICAL INDUSTRIES, INC. FORM 8-K SEPTEMBER 22, 2008 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): September 22, 2008 PARADIGM MEDICAL INDUSTRIES, INC. (Exact name of registrant as specified in this Charter) Delaware 0-28498 87-0459536 (State or other jurisdiction of in |
|
| August 20, 2008 |
FORM 8-K/A-4 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 26, 2008 PARADIGM MEDICAL INDUSTRIES, INC. |
|
| August 19, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2008 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 0-28498 PARADIGM MEDICAL INDUSTRIES, INC. (Exact name of regis |
|
| August 18, 2008 |
FORM 8-K/A-3 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): August 12, 2008 PARADIGM MEDICAL INDUSTRIES, INC. |
|
| July 10, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant : Filed by a Party other than the Registrant 9 Check the appropriate box: : Preliminary Proxy Statement 9 Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(3)(2)) 9 Definitive Proxy Statement 9 Definitive Additional Materials 9 Soliciting Material Pursuant to ?240. |
|
| June 24, 2008 |
PARADIGM MEDICAL INDUSTRIES, INC. 2355 South 1070 West Salt Lake City, Utah 84119 USA Telephone: (801) 977-8970 Facsimile: (801) 977-8973 June 23, 2008 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E., Mail Stop 6010 Washington, D.C. 20549 Attn: Kevin L. Vaughn Accounting Branch Chief Re: Paradigm Medical Industries, Inc. Form 10-KSB for the Fiscal Ye |
|
| June 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. FORM 10-QSB x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 0-28498 PARADIGM MEDICAL INDUSTRIES, INC. (Exact name o |
|
| June 13, 2008 |
FORM 8-K/A-2 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 26, 2008 PARADIGM MEDICAL INDUSTRIES, INC. |
|
| June 2, 2008 |
FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 12, 2008 PARADIGM MEDICAL INDUSTRIES, INC. |
|
| May 30, 2008 |
MACKEY PRICE THOMPSON & OSTLER A Professional Corporation Attorneys and Counselors at Law American Plaza II 57 West 200 South, Suite 350 Salt Lake City, UT 84101-3663 Telephone 801-575-5000 Randall A. |
|
| May 30, 2008 |
PARADIGM MEDICAL INDUSTRIES, INC. May 30, 2008 PARADIGM MEDICAL INDUSTRIES, INC. May 30, 2008 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: David Burton Staff Accountant Re: Paradigm Medical Industries, Inc. Item 4.02 Form 8-K/A File No. 0-28498 Dear Mr. Burton: In connection with responding to the comment letter on the above-referenced Form 8-K, the Company hereby ac |
|
| February 14, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. |
|
| October 3, 2001 |
<META NAME="Generator" CONTENT="Microsoft Word 97"> 3: e13g UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Paradigm Medical Industries, Inc. (Name of Issuer) Common Stock, par value $.001 per |
|
| August 7, 2000 |
AGREEMENT OF MERGER - This Agreement of Merger (this "Merger Agreement') dates as of June 5, 2000, is entered into by and among Paradigm Medical Industries, Inc. |
|
| June 20, 2000 |
